Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eye Movements | 5 | 2025 | 86 | 2.040 |
Why?
|
| Diagnostic Errors | 2 | 2025 | 106 | 1.660 |
Why?
|
| Radiologists | 2 | 2025 | 95 | 1.490 |
Why?
|
| Cues | 4 | 2017 | 81 | 1.200 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2026 | 1665 | 1.040 |
Why?
|
| Columbidae | 1 | 2026 | 15 | 0.950 |
Why?
|
| Cocaine-Related Disorders | 2 | 2017 | 81 | 0.940 |
Why?
|
| Learning | 2 | 2023 | 186 | 0.900 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2025 | 21 | 0.860 |
Why?
|
| Radiography, Thoracic | 1 | 2025 | 117 | 0.830 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2025 | 96 | 0.820 |
Why?
|
| Electrocardiography | 1 | 2025 | 556 | 0.740 |
Why?
|
| Attention | 3 | 2016 | 154 | 0.680 |
Why?
|
| Craving | 3 | 2017 | 38 | 0.590 |
Why?
|
| Saccades | 3 | 2016 | 15 | 0.560 |
Why?
|
| Lung Neoplasms | 1 | 2025 | 712 | 0.540 |
Why?
|
| Visual Perception | 3 | 2026 | 51 | 0.510 |
Why?
|
| Reward | 2 | 2007 | 89 | 0.480 |
Why?
|
| Volition | 1 | 2016 | 11 | 0.480 |
Why?
|
| Anxiety Disorders | 1 | 2017 | 201 | 0.460 |
Why?
|
| Depressive Disorder | 1 | 2017 | 284 | 0.440 |
Why?
|
| Cognition | 3 | 2017 | 514 | 0.420 |
Why?
|
| Cognition Disorders | 1 | 2015 | 224 | 0.390 |
Why?
|
| Smoking | 1 | 2015 | 864 | 0.320 |
Why?
|
| Lung | 2 | 2026 | 969 | 0.310 |
Why?
|
| Psychomotor Performance | 3 | 2006 | 139 | 0.270 |
Why?
|
| Heroin Dependence | 2 | 2017 | 21 | 0.260 |
Why?
|
| Male | 11 | 2025 | 31398 | 0.250 |
Why?
|
| Models, Psychological | 1 | 2007 | 102 | 0.250 |
Why?
|
| Female | 11 | 2025 | 34414 | 0.250 |
Why?
|
| Punishment | 1 | 2006 | 4 | 0.250 |
Why?
|
| Models, Neurological | 1 | 2007 | 83 | 0.250 |
Why?
|
| Buprenorphine, Naloxone Drug Combination | 2 | 2017 | 26 | 0.250 |
Why?
|
| Choice Behavior | 1 | 2007 | 86 | 0.240 |
Why?
|
| Humans | 17 | 2025 | 65826 | 0.230 |
Why?
|
| Opioid-Related Disorders | 3 | 2018 | 532 | 0.230 |
Why?
|
| Opiate Substitution Treatment | 3 | 2017 | 226 | 0.230 |
Why?
|
| Adult | 10 | 2018 | 17567 | 0.220 |
Why?
|
| Illusions | 1 | 2003 | 1 | 0.210 |
Why?
|
| Sensitivity and Specificity | 1 | 2025 | 1172 | 0.180 |
Why?
|
| Middle Aged | 4 | 2025 | 18491 | 0.180 |
Why?
|
| Frontal Lobe | 1 | 2001 | 63 | 0.170 |
Why?
|
| Reproducibility of Results | 1 | 2025 | 1720 | 0.160 |
Why?
|
| Substance-Related Disorders | 2 | 2018 | 757 | 0.160 |
Why?
|
| Young Adult | 5 | 2017 | 4878 | 0.160 |
Why?
|
| Reaction Time | 3 | 2006 | 134 | 0.160 |
Why?
|
| Clinical Competence | 1 | 2025 | 731 | 0.150 |
Why?
|
| Memantine | 2 | 2017 | 22 | 0.150 |
Why?
|
| Prescription Drug Overuse | 1 | 2018 | 7 | 0.140 |
Why?
|
| Brain | 1 | 2007 | 1672 | 0.140 |
Why?
|
| Eye Movement Measurements | 1 | 2017 | 20 | 0.130 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2017 | 26 | 0.130 |
Why?
|
| Psychological Tests | 1 | 2017 | 48 | 0.130 |
Why?
|
| Interview, Psychological | 1 | 2017 | 79 | 0.130 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2017 | 91 | 0.130 |
Why?
|
| Prospective Studies | 1 | 2025 | 3339 | 0.130 |
Why?
|
| Drug Prescriptions | 1 | 2018 | 165 | 0.130 |
Why?
|
| Executive Function | 1 | 2017 | 71 | 0.130 |
Why?
|
| Cocaine | 1 | 2017 | 101 | 0.120 |
Why?
|
| Drug Overdose | 1 | 2018 | 123 | 0.120 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2017 | 84 | 0.120 |
Why?
|
| Affect | 1 | 2017 | 132 | 0.120 |
Why?
|
| Methadone | 1 | 2017 | 140 | 0.120 |
Why?
|
| Chronic Pain | 1 | 2018 | 157 | 0.120 |
Why?
|
| Naloxone | 1 | 2015 | 53 | 0.110 |
Why?
|
| Aging | 1 | 2001 | 784 | 0.110 |
Why?
|
| Motor Activity | 1 | 2017 | 347 | 0.110 |
Why?
|
| Narcotic Antagonists | 1 | 2015 | 133 | 0.100 |
Why?
|
| Adolescent | 4 | 2017 | 6367 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 1568 | 0.090 |
Why?
|
| Analgesics, Opioid | 1 | 2017 | 533 | 0.090 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 603 | 0.090 |
Why?
|
| Mental Disorders | 1 | 2018 | 827 | 0.080 |
Why?
|
| Veterans | 1 | 2017 | 770 | 0.080 |
Why?
|
| Animals | 1 | 2026 | 21489 | 0.070 |
Why?
|
| Tobacco Use Disorder | 1 | 2010 | 248 | 0.060 |
Why?
|
| Alcoholism | 1 | 2010 | 329 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 132 | 0.060 |
Why?
|
| Photic Stimulation | 1 | 2005 | 89 | 0.060 |
Why?
|
| Age Factors | 2 | 2017 | 1595 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2006 | 606 | 0.060 |
Why?
|
| Smoking Cessation | 1 | 2010 | 553 | 0.050 |
Why?
|
| Superior Colliculi | 1 | 2003 | 12 | 0.050 |
Why?
|
| Visual Cortex | 1 | 2003 | 29 | 0.050 |
Why?
|
| Functional Laterality | 1 | 2001 | 141 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2001 | 420 | 0.040 |
Why?
|
| Colombia | 1 | 2017 | 22 | 0.030 |
Why?
|
| Psychotherapy, Group | 1 | 2017 | 34 | 0.030 |
Why?
|
| Needle Sharing | 1 | 2017 | 14 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 375 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 463 | 0.030 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2017 | 126 | 0.030 |
Why?
|
| Comorbidity | 1 | 2018 | 1122 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2015 | 747 | 0.020 |
Why?
|
| Recurrence | 1 | 2015 | 665 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 859 | 0.020 |
Why?
|
| Massachusetts | 1 | 2018 | 2158 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2001 | 2324 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2790 | 0.020 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2010 | 104 | 0.020 |
Why?
|
| Behavior Therapy | 1 | 2010 | 169 | 0.020 |
Why?
|
| Neoplasms | 1 | 2018 | 1377 | 0.020 |
Why?
|
| Child | 1 | 2017 | 4653 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2018 | 6953 | 0.010 |
Why?
|
| Aged | 1 | 2001 | 15141 | 0.010 |
Why?
|